心血管疾患の増加
世界保健機関（WHO）によると、年間1,790万人が死亡しており、心血管疾患（CVD）は世界的な死亡原因の第1位です。冠動脈性心疾患、脳血管疾患、リウマチ性心疾患、その他の疾患は、CVDとして知られる心臓や血管の疾患のカテゴリーに含まれます。CVDによる死亡者の5人に4人以上が心臓発作と脳卒中であり、その3分の1が70歳までに死亡しています。
Journal of the American College of Cardiology誌に発表された研究によると、2060年までに米国では心血管系の危険因子と疾患の推定割合が大幅に上昇するという。心血管系の傾向の大幅な上昇は、米国の医療制度に大きな負担をかける可能性があり、教育や治療を含む早期の疾病予防サービスへの公平なアクセスの必要性を強調するものです。
地域別
• 北米
o 米国
カナダ
メキシコ
• ヨーロッパ
o ドイツ
o イギリス
o フランス
o イタリア
o スペイン
o その他のヨーロッパ
• 南アメリカ
o ブラジル
o アルゼンチン
o その他の南米諸国
• アジア太平洋
o 中国
o インド
o 日本
o オーストラリア
o その他のアジア太平洋地域
• 中東およびアフリカ
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by End-users
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. FDA Approval
4.1.1.2. Active Major Players
4.1.1.3. Increasing Collaboration Among Key Players
4.1.1.4. Increasing Prevalence of Cardiovascular Diseases
4.1.2. Restraints
4.1.2.1. High Cost of Devices
4.1.2.2. Technical Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Embolectomy Balloon Catheter*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Catheter Directed Thrombolysis Devices
7.4. Percutaneous Thrombectomy Devices
7.5. Inferior Vena cava Filters
7.6. Neurovascular Embolectomy Devices
7.7. Others
8. By End-user
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
8.1.2. Market Attractiveness Index, By End-user
8.2. Commercial and Infrastructure*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Residential
8.4. Industrial
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Medtronic Plc*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Boston Scientific Corporation
11.3. Edward Lifesciences
11.4. Teleflex Incorporated
11.5. Johnson & Johnson
11.6. LeMaitre Vascular, Inc.
11.7. AngioDynamics
11.8. iVascular SLU
11.9. Cardinal Health
11.10. Stryker
12. Appendix
12.1. About Us and Services
12.2. Contact Us
